Read about some of our success stories.
Macomics is an immuno-oncology company with world-leading expertise in macrophage biology.
University of Edinburgh spinout company Pheno Therapeutics develops therapeutics to improve the lives of multiple sclerosis (MS) patients.
Biotechnology spinout company Resolution Therapeutics develop macrophage cell therapies to treat diseases characterised by life-threatening inflammatory organ damage.
A collaborative research project betweenresearchers in healthcare and computer sciences at the University of Edinburgh led to the launch of spinout company SpeakUnique, which provides voice banking technology for people to communicate in their own voice when natural speech is not possible